High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study.

Ibrahim, A; Zambon, E; Bourhis, J H; Ostronoff, M; Beaujean, F; Viens, P; Lhomme, C; Chazard, M; Maraninchi, D; Hayat, M

Ibrahim, A; Zambon, E; Bourhis, J H; Ostronoff, M; Beaujean, F; Viens, P; Lhomme, C; Chazard, M; Maraninchi, D; Hayat, M.

Affiliation

Ibrahim A; Department of Medicine, Institut Gustave Roussy, Villejuif, France.

Eur J Cancer ; 29A(10): 1398-403, 1993.

Article in En | MEDLINE | ID: mdl-8398267

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Bone Marrow Transplantation; Neoplasms/therapy; Adolescent; Adult; Agranulocytosis/etiology; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Carboplatin/administration & dosage; Combined Modality Therapy; Cyclophosphamide/administration & dosage; Etoposide/administration & dosage; Female; Humans; Male; Middle Aged; Pilot Projects; Prognosis; Prospective Studies; Salvage Therapy; Thrombocytopenia/etiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Bone Marrow Transplantation / Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 1993 Document type: Article Affiliation country: France Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links